Funding for this research was provided by:
MSD Avenir Fund
Received: 26 April 2021
Accepted: 30 January 2022
First Online: 12 February 2022
: Information regarding the collection of individual data, with the aim of performing research on routine care, was provided to the patients. This research is an ancillary study of the MEMORA cohort. This ancillary study, conducted in routine care, was considered noninterventional by the local ethics committee CPP Lyon Sud-Est IV (<i>Comité de Protection des Personnes</i> [Committee for the Protection of People]). No signed consent to participate was required, but patients may refuse the use of their data for research purpose. Authorization for handling personal data was granted by the representative of the French Data Protection Authority, <i>CNIL: Commission Nationale de l’Informatique et Libertés</i>. All procedures are in compliance with the Declaration of Helsinki. The MEMORA cohort also obtained agreements from the regional ethics committee (Comité de Protection des Personnes Sud Est III) and the French Data Protection Authority (NCT02302482).
: Not applicable.
: Mihaela Levitchi-Benea and Ivana Rubino are employees of Biogen, Cambridge, MA, USA. Michele Potashman and Ray Su were employees of Biogen at the time this work was conducted. Virginie Dauphinot and Pierre Krolak-Salmon are employees of the Lyon University Hospital and University of Lyon, France.